1. Expression defect of the rare variant/Brugada mutation R1512W depends upon the SCN5A splice variant background and can be rescued by mexiletine and the common polymorphism H558R. Issue 1 (1st January 2021) Authors: Hu, Rou-Mu; Song, Evelyn J.; Tester, David J.; Deschenes, Isabelle; Ackerman, Michael J.; Makielski, Jonathan C.; Tan, Bi-Hua Journal: Channels Issue: Volume 15:Issue 1(2021) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients. Issue 1 (1st January 2018) Authors: Hu, Rou-Mu; Tester, David J.; Li, Ryan; Sun, Tianyu; Peterson, Blaise Z.; Ackerman, Michael J.; Makielski, Jonathan C.; Tan, Bi-Hua Journal: Channels Issue: Volume 12:Issue 1(2018) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SYNERGISTIC EFFECT OF THE NOVEL MUTATIONS IN SCN5A AND SNTA1 ON LATE INA CONTRIBUTING TO LQT SYNDROME. (8th October 2012) Authors: Hu, Rou-Mu; Pu, Jielin Journal: Heart Issue: Volume 98(2012)Supplement 2 Page Start: E82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗